Skip to main content
. 2012 Jul 10;36(5):437–448. doi: 10.1111/j.1365-2036.2012.05208.x

Figure 3.

Figure 3

Mean number of days IBS symptoms interfered with (a) social/leisure and (b) household activities at baseline and Week 12 for the placebo (PBO) and alosetron treatment groups. BL, baseline; QD, once daily; BID, twice daily. **P < 0.01, significantly different from placebo.